Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Infulgan"'
Publikováno v:
Медицина болю, Vol 5, Iss 1, Pp 5-13 (2020)
There is no “gold standard” for the treatment of postoperative pain. According to statistics, from 30 to 75% of patients in the surgical departments continue to suffer from severe pain. Objective. To assess the practical relevance and quality of
Externí odkaz:
https://doaj.org/article/74bd1edd14d7401586efea16d51d2d1d
Autor:
D. E. Korenyuk, A. G. Tkachuk, Yu. M. Terzi, V. Ya. Lagunov, A. G. Antonenko, E. V. Kolokolnikova
Publikováno v:
Медицина болю, Vol 3, Iss 1, Pp 43-46 (2018)
The article presents the study of the use of parenteral forms of drugs Infulgan and Nalbuphine on the base of the Regional Mammological Center and the Department of Anesthesiology N 1 of Clinical Oncology Dispensary (Dnipro). We have generalized the
Externí odkaz:
https://doaj.org/article/caf4c39cee1d402c83835c5f9f8fda8b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Медицина болю, Vol 5, Iss 1, Pp 5-13 (2020)
Medicina bolu; Том 5 № 1 (2020): Pain medicine; 5-13
Pain medicine; Vol 5 No 1 (2020): Pain medicine; 5-13
Medicina bolu; Том 5 № 1 (2020): Pain medicine; 5-13
Pain medicine; Vol 5 No 1 (2020): Pain medicine; 5-13
There is no “gold standard” for the treatment of postoperative pain. According to statistics, from 30 to 75% of patients in the surgical departments continue to suffer from severe pain.Objective. To assess the practical relevance and quality of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f8cd32b1af467fad9c64a7780d87bab
https://painmedicine.org.ua/index.php/pnmdcn/article/view/214
https://painmedicine.org.ua/index.php/pnmdcn/article/view/214
Autor:
D. E. Korenyuk, A. G. Antonenko, Yu. M. Terzi, V. Ya. Lagunov, E. V. Kolokolnikova, A. G. Tkachuk
Publikováno v:
Medicina bolu; Том 3 № 1 (2018): Medicina bolu; 43-46
Pain medicine; Vol 3 No 1 (2018): Pain medicine; 43-46
Медицина болю, Vol 3, Iss 1, Pp 43-46 (2018)
Pain medicine; Vol 3 No 1 (2018): Pain medicine; 43-46
Медицина болю, Vol 3, Iss 1, Pp 43-46 (2018)
The article presents the study of the use of parenteral forms of drugs Infulgan and Nalbuphine on the base of the Regional Mammological Center and the Department of Anesthesiology N 1 of Clinical Oncology Dispensary (Dnipro). We have generalized the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f7a309748cacd5712ad27b476184ae9
https://painmedicine.org.ua/index.php/pnmdcn/article/view/86
https://painmedicine.org.ua/index.php/pnmdcn/article/view/86
Publikováno v:
Health of Man; № 2(57) (2016): Health of men; 27-28
Здоровье мужчины; № 2(57) (2016); 27-28
Здоров'я чоловіка; № 2(57) (2016): Здоров'я чоловіка; 27-28
Здоровье мужчины; № 2(57) (2016); 27-28
Здоров'я чоловіка; № 2(57) (2016): Здоров'я чоловіка; 27-28
The article presents data illustrating the high clinical efficacy and safety of using an injectable form of paracetamol. The use of strong analgesic of Infulgan («Yuria-Pharm», Ukraine) is real and safe, as evidenced by the results of the research.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=scientific_p::bf8ade37a2c58370eede28c23bb653dd
http://health-man.com.ua/article/view/82937
http://health-man.com.ua/article/view/82937
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Здоровье мужчины, Vol 0, Iss 2 (57), Pp 27-28 (2016)
The article presents data illustrating the high clinical efficacy and safety of using an injectable form of paracetamol. The use of strong analgesic of Infulgan («Yuria-Pharm», Ukraine) is real and safe, as evidenced by the results of the research.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2dea7b6f9d0dc596e6cb8e226cafb0
https://doi.org/10.30841/2307-5090.2(57).2016.82937
https://doi.org/10.30841/2307-5090.2(57).2016.82937